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Mutations in receptor tyrosine kinase/RAS signaling pathway genes are frequent in
core-binding factor (CBF) acute myeloid leukemias (AMLs), but their prognostic
relevance is debated. A subset of CBF AML patients harbors several signaling gene
mutations. Genotyping of colonies and of relapse samples indicates that these arise
in independent clones, thus defining a process of clonal interference (or parallel
evolution). Clonal interference is pervasive in cancers, but the mechanisms
underlying this process remain unclear, and its prognostic impact remains unknown.
We analyzed a cohort of 445 adult and pediatric patients with CBF AML treated with
intensive chemotherapy and with deep sequencing of 6 signaling genes (, , , , , ). A
total of 152 (34%), 167 (38%), and 126 (28%) patients harbored no, a single, and
multiple signaling clones (clonal interference), respectively. Clonal interference of
signaling mutations was associated with older age ( = .004) and inv(16) subtype ( =
.025) but not with white blood cell count or mutations in chromatin or cohesin genes.
The median allele frequency of signaling mutations was 31% in patients with a single
clone or clonal interference ( = .14). The repertoire of , , and / variants differed
between groups. Clonal interference did not affect complete remission rate or
minimal residual disease after 1-2 courses, but it did convey inferior event-free
survival ( < 10), whereas the presence of a single signaling clone did not ( = .44).
This inferior outcome was independent of clinical parameters and of the presence of
specific signaling clones. Our results suggest that specific clonal architectures can
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